Drugs / SSR180575
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00502515 | Jul 2007 → Feb 2009 | diabetic neuropathy | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SSR180575 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00502515 ↗ |
| Route | Oral | “Oral, once daily dosing” NCT00502515 ↗ |